| 12377150 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson |
2025-08-05 |
|
| 12350311 |
Gene therapy for neurodegenerative disorders |
Lamya Shihabuddin, Seng H. Cheng |
2025-07-08 |
|
| 12121532 |
Modified antisense oligomers for exon inclusion in spinal muscular atrophy |
Gunnar J. Hanson |
2024-10-22 |
$192,614,000 |
| 11975043 |
Gene therapy for neurodegenerative disorders |
Lamya Shihabuddin, Seng H. Cheng |
2024-05-07 |
|
| 11957765 |
Gene therapy for neurometabolic disorders |
James Dodge |
2024-04-16 |
|
| 11911440 |
Gene therapy for neurodegenerative disorders |
Lamya Shihabuddin, Seng H. Cheng |
2024-02-27 |
|
| 11642364 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson |
2023-05-09 |
$119,218,000 |
| 11395855 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson |
2022-07-26 |
$75,576,000 |
| 11382981 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson |
2022-07-12 |
$38,487,000 |
| 11338041 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson, Frederick Joseph SCHNELL |
2022-05-24 |
$63,747,000 |
| 11253485 |
Slow intraventricular delivery |
James Dodge, Lamya Shihabuddin, Seng H. Cheng |
2022-02-22 |
|
| 11000600 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson |
2021-05-11 |
$92,984,000 |
| 10913956 |
Gene therapy for neurometabolic disorders |
Greg Stewart, James Dodge |
2021-02-09 |
|
| 10905709 |
Modified antisense oligomers for exon inclusion in spinal muscular atrophy |
Gunnar J. Hanson |
2021-02-02 |
$39,029,000 |
| 10888578 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson |
2021-01-12 |
$113,442,000 |
| 10821154 |
Compositions and methods for treating spinal muscular atrophy |
Lamya Shihabuddin, Catherine R. O'Riordan, Seng H. Cheng |
2020-11-03 |
|
| 10765760 |
Exon skipping oligomer conjugates for muscular dystrophy |
Gunnar J. Hanson, Frederick Joseph SCHNELL |
2020-09-08 |
$125,532,000 |
| 10744210 |
Gene therapy for spinal cord disorders |
James Dodge, Lamya Shihabuddin, Seng H. Cheng, Catherine R. O'Riordan |
2020-08-18 |
|
| 10632213 |
Gene therapy for neurometabolic disorders |
James Dodge |
2020-04-28 |
|
| 10369193 |
Gene therapy for neurodegenerative disorders |
Lamya Shihabuddin, Seng H. Cheng |
2019-08-06 |
|
| 10080783 |
Intraventricular enzyme delivery for lysosomal storage diseases |
James Dodge, Lamya Shihabuddin, Seng H. Cheng |
2018-09-25 |
|
| 9717750 |
Compositions and methods for modulation of SMN2 splicing in a subject |
C. Frank Bennett, Gene Hung, Frank Rigo, Adrian R. Krainer, Yimin Hua +3 more |
2017-08-01 |
$359,535,000 |
| 9415119 |
Gene therapy for neurodegenerative disorders |
Lamya Shihabuddin, Seng H. Cheng |
2016-08-16 |
|
| 8980853 |
Compositions and methods for modulation of SMN2 splicing in a subject |
C. Frank Bennett, Gene Hung, Frank Rigo, Adrian R. Krainer, Yimin Hua +3 more |
2015-03-17 |
$122,925,000 |
| 8926967 |
Intraventricular enzyme delivery for lysosomal storage diseases |
James Dodge, Lamya Shihabuddin, Seng H. Cheng |
2015-01-06 |
|